Amellnova AB is a medtech company located in Uppsala, Sweden. Amellnova develops, manufactures and markets products in the ENT (Ear-Nose-Throat) area. The company’s quality work is performed according to the principles of ISO 13485.
Otinova is a non-prescription, self-care product that prevents and treats ear canal inflammation known as otitis externa or swimmer’s ear. Both adults and children can use Otinova, which is easy to apply with its spray function. After treatment, itching and pain in the ears disappear. Unlike many prescription ear drops Otinova is completely free of antibiotics.
Otinova acts locally and has antibacterial, antimycotic, astringent and decongestant effects. The antimicrobial and clinical effects of Otinova are scientifically and clinically documented.
Otinova is the only medical device that is registered with the Medical Products Agency for the indication prophylaxis and treatment of otitis externa. Otinova is classified as a medical device, class I, according to rule 5 in Annex IX of the MDD 93/42/EEC.
Otinova is available in pharmacies in Sweden, Norway and Denmark.
Company’s Keywords:
<1
<
<2009